Contribution Of Pharmaceutical Services For The Improvement Of The Quality Of Life Of Htlv Carriers
International Journal of Development Research
Contribution Of Pharmaceutical Services For The Improvement Of The Quality Of Life Of Htlv Carriers
Received 17th December, 2018; Received in revised form 12th January, 2019; Accepted 15th February, 2019; Published online 31st March, 2019
Copyright © 2019, Chyslany Amaral dos Santos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
HTLV virus belongs to the family Retroviridae, being the first retrovirus found in humans. HTLV type 1 (HTLV-1) was initially related to T-cell leukemia. This study aimed to describe the importance of pharmaceutical services for the treatment of HTLV patients. The bibliographic search was carried out in the last ten years, in studies to the electronic databases such as: Scielo, Bireme, Fiocruz, website of the Federal Council of Pharmacy, Ministry of Health. The following descriptors were used for online research: HTLV, epidemiology, pharmaceutical, pharmaceutical attention. After the analysis of the reading of the files found, it was observed its publication time and fit the proposal to be reached within the chosen theme. The included publications for the study were in Portuguese language with the period of publication within the established. In total, 26 articles were chosen with the proposed theme, and after analysis only those that fit the chosen theme were used. With the elaboration of this study it was possible to reach the conclusion about the importance of the pharmaceutical professional in the treatment of HTLV virus carriers and in the pharmacotherapeutic aid, and in the improvement of the quality of life of these individuals.